129 related articles for article (PubMed ID: 22903668)
1. Naturally occurring autoantibodies against β-Amyloid.
Bach JP; Dodel R
Adv Exp Med Biol; 2012; 750():91-9. PubMed ID: 22903668
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.
Dodel R; Balakrishnan K; Keyvani K; Deuster O; Neff F; Andrei-Selmer LC; Röskam S; Stüer C; Al-Abed Y; Noelker C; Balzer-Geldsetzer M; Oertel W; Du Y; Bacher M
J Neurosci; 2011 Apr; 31(15):5847-54. PubMed ID: 21490226
[TBL] [Abstract][Full Text] [Related]
4. Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.
Cao H; Du X; Zeng R; Lv Z; Ye S; Jiang P; Wang Z; Ma L; Huang Y; Li C; Zhang R; Liu F
Curr Alzheimer Res; 2019; 16(14):1290-1299. PubMed ID: 31894747
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence.
Dodel R; Neff F; Noelker C; Pul R; Du Y; Bacher M; Oertel W
Drugs; 2010 Mar; 70(5):513-28. PubMed ID: 20329802
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta.
Balakrishnan K; Andrei-Selmer LC; Selmer T; Bacher M; Dodel R
J Alzheimers Dis; 2010; 20(1):135-43. PubMed ID: 20164596
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment.
Mengel D; Röskam S; Neff F; Balakrishnan K; Deuster O; Gold M; Oertel WH; Bacher M; Bach JP; Dodel R
Transl Psychiatry; 2013 Mar; 3(3):e236. PubMed ID: 23462987
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
[TBL] [Abstract][Full Text] [Related]
9. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R
PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
Dodel RC; Du Y; Depboylu C; Hampel H; Frölich L; Haag A; Hemmeter U; Paulsen S; Teipel SJ; Brettschneider S; Spottke A; Nölker C; Möller HJ; Wei X; Farlow M; Sommer N; Oertel WH
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1472-4. PubMed ID: 15377700
[TBL] [Abstract][Full Text] [Related]
11. Vaccines: chasing the dream.
Schnabel J
Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
[No Abstract] [Full Text] [Related]
12. Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG?
Warrington AE; Van Keulen V; Pease LR; Rodriguez M
Adv Exp Med Biol; 2012; 750():44-55. PubMed ID: 22903665
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies.
Klaver AC; Coffey MP; Smith LM; Loeffler DA
Immunol Lett; 2013; 154(1-2):7-11. PubMed ID: 23928186
[TBL] [Abstract][Full Text] [Related]
14. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
Kronimus Y; Albus A; Balzer-Geldsetzer M; Straub S; Semler E; Otto M; Klotsche J; Dodel R; ; Mengel D
PLoS One; 2016; 11(11):e0164953. PubMed ID: 27802290
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia.
Gold M; Mengel D; Röskam S; Dodel R; Bach JP
J Neuroinflammation; 2013 Jan; 10():5. PubMed ID: 23317003
[TBL] [Abstract][Full Text] [Related]
16. Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.
Paul S; Planque S; Nishiyama Y
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S43-9. PubMed ID: 20454852
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulins for Alzheimer's disease.
Puli L; Tanila H; Relkin N
Curr Alzheimer Res; 2014; 11(7):626-36. PubMed ID: 25115546
[TBL] [Abstract][Full Text] [Related]
18. Multi-faceted role of naturally occurring autoantibodies in fighting pathogens.
Bouhlal H; Kaveri S
Adv Exp Med Biol; 2012; 750():100-13. PubMed ID: 22903669
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of intravenous immunoglobulin for Alzheimer's disease.
Relkin N
J Clin Immunol; 2014 Jul; 34 Suppl 1():S74-9. PubMed ID: 24760112
[TBL] [Abstract][Full Text] [Related]
20. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
